Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes.
暂无分享,去创建一个
[1] A. J. Gandolfi,et al. Hepatotoxicological evaluation of dantrolene sodium. , 1984, Drug and chemical toxicology.
[2] W. Inman,et al. Erythromycin estolate and jaundice. , 1983, British medical journal.
[3] J. Jalife,et al. Dantrolene sodium: effects on isolated cardiac tissues. , 1983, Journal of molecular and cellular cardiology.
[4] Arnold Th,et al. Dantrolene sodium: urinary metabolites and hepatotoxicity. , 1983 .
[5] H. Lüllmann,et al. A comparison of the effect of dantrolene upon the contractile response of different heart muscles and of a skeletal muscle preparation. , 1982, Pharmacological Research Communications.
[6] D. Conte Camerino,et al. Effects of dantrolene sodium on the contractile properties of isolated guinea-pig pyeloureter. , 1982, Pharmacological research communications.
[7] D. Acosta,et al. Metabolic activation and cytotoxicity of cyclophosphamide in primary cultures of postnatal rat hepatocytes. , 1981, Biochemical pharmacology.
[8] D. Acosta,et al. Evaluation of the cytotoxicity of tricyclic antidepressants in primary cultures of rat hepatocytes. , 1981, Journal of toxicology and environmental health.
[9] D. Acosta,et al. Evaluation of cytotoxicity in cultured cells by enzyme leakage , 1980 .
[10] Toshikazu Nakamura,et al. BIOCHEMICAL FUNCTIONS OF ADULT RAT HEPATOCYTES IN PRIMARY CULTURE * , 1980, Annals of the New York Academy of Sciences.
[11] M. Csuka,et al. Erythromycin ethylsuccinate hepatotoxicity. , 1980, JAMA.
[12] S. Roy,et al. Interaction of dantrolene with the hepatic mixed function oxidase system. , 1980, Research communications in chemical pathology and pharmacology.
[13] H. Zimmerman,et al. Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: A brief note , 1980, Mechanisms of Ageing and Development.
[14] C. Dujovne,et al. Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems. , 1980, Pharmacology.
[15] D. Pessayre,et al. Hepatotoxicity of erythromycin derivatives. , 1979, British medical journal.
[16] Hamrick Me,et al. Dantrolene inhibition of the hepatic mixed function oxidase system. , 1979 .
[17] E. Hodgson,et al. Reviews in biochemical toxicology , 1979 .
[18] H. Zimmerman,et al. The effects of dantrolene sodium on excretory function in the isolated perfused rat liver. , 1978, Toxicology and applied pharmacology.
[19] J. Lloyd-Still,et al. Erythromycin estolate hepatotoxicity. , 1978, A M A Journal of Diseases of Children.
[20] C. Dujovne. Hepatotoxic and cellular uptake interactions among surface active components of erythromycin preparations. , 1978, Biochemical Pharmacology.
[21] E. Kass,et al. Hepatotoxicity of Erythromycin Estolate During Pregnancy , 1977, Antimicrobial Agents and Chemotherapy.
[22] J. Boitnott,et al. Dantrolene-associated hepatic injury. Incidence and character. , 1977, Gastroenterology.
[23] A. Gildon,et al. Erythromycin Estolate Induced Hepatotoxicity , 1977 .
[24] H. Eichenwald,et al. Erythromycin: a review of its uses in pediatric practice. , 1976, The Journal of pediatrics.
[25] S. Huang,et al. Jaundice due to erythromycin estolate. , 1975, Gastroenterology.
[26] M. H. Dykes. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium). , 1975, JAMA.
[27] J. Freston,et al. Chemical structure of erythromycin and hepatotoxicity. , 1974, Annals of internal medicine.
[28] Basmajian Jv,et al. Dantrolene sodium: long-term effects in severe spasticity. , 1973 .
[29] R. Herman,et al. Treatment of spasticity with dantrolene sodium. , 1973, American Journal of Physical Medicine.
[30] C. Dujovne,et al. Toxicity of a hepatotoxic laxative preparation in tissue culture and excretion in bile in man , 1972, Clinical pharmacology and therapeutics.
[31] L. Lasagna,et al. Experimental bases for the different hepatotoxicity of erythromycin preparations in man. , 1972, The Journal of laboratory and clinical medicine.
[32] H. Leffert,et al. STUDIES ON PRIMARY CULTURES OF DIFFERENTIATED FETAL LIVER CELLS , 1972, The Journal of cell biology.
[33] L. Lasagna,et al. Toxicity of hepatotoxic drugs on mouse liver tissue culture. , 1970, Archives internationales de pharmacodynamie et de therapie.
[34] P. Braun. Hepatotoxicity of erythromycin. , 1969, The Journal of infectious diseases.
[35] H. Fischer,et al. MIMICRY OF ACUTE CHOLECYSTITIS BY ERYTHROMYCIN ESTOLATE REACTIONS. REPORT OF 2 CASES , 1964, The American journal of the medical sciences.
[36] A. Brown. Two Cases of Untoward Reaction after“Ilosone” , 1963, British medical journal.
[37] M. M. Robinson. HEPATIC DYSFUNCTION ASSOCIATED WITH TRIACETYLOLEANDOMYCIN AND PROPIONYL ERYTHROMYCIN ESTER LAURYL SULFATE , 1962, The American journal of the medical sciences.
[38] O. H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[39] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .